Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Urology. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

featured

Journal Scan / Research · June 05, 2019

Early Detection and Monitoring of Urothelial Bladder Carcinoma by Ultra-Deep Sequencing of ctDNA

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
J. Clin. Oncol 2019 May 06;[EPub Ahead of Print], E Christensen, K Birkenkamp-Demtröder, H Sethi, S Shchegrova, R Salari, I Nordentoft, HT Wu, M Knudsen, P Lamy, SV Lindskrog, A Taber, M Balcioglu, S Vang, Z Assaf, S Sharma, AS Tin, R Srinivasan, D Hafez, T Reinert, S Navarro, A Olson, R Ram, S Dashner, M Rabinowitz, P Billings, S Sigurjonsson, CL Andersen, R Swenerton, A Aleshin, B Zimmermann, M Agerbæk, CJ Lin, JB Jensen, L Dyrskjøt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading